KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Equity (2016 - 2025)

Edwards Lifesciences has reported Return on Equity over the past 16 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Equity at 0.0% for Q4 2025, down 28.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 28.0% YoY), and the annual figure for FY2025 was 0.0%, down 33.0%.
  • Return on Equity for Q4 2025 was 0.0% at Edwards Lifesciences, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for EW hit a ceiling of 0.32% in Q3 2024 and a floor of 0.0% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.23% (2022), compared with a mean of 0.18%.
  • Biggest five-year swings in Return on Equity: grew 27bps in 2024 and later plummeted -32bps in 2025.
  • Edwards Lifesciences' Return on Equity stood at 0.26% in 2021, then decreased by -17bps to 0.22% in 2022, then plummeted by -88bps to 0.03% in 2023, then soared by 957bps to 0.28% in 2024, then plummeted by -100bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.26% (Q2 2025) per Business Quant data.